Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
5.26
+0.04 (0.77%)
At close: May 27, 2026, 4:00 PM EDT
5.30
+0.04 (0.76%)
After-hours: May 27, 2026, 7:54 PM EDT

Minerva Neurosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
32.7682.421.4641.0136.1960.86
Short-Term Investments
45.41-----
Cash & Short-Term Investments
78.1682.421.4641.0136.1960.86
Cash Growth
349.48%283.94%-47.67%13.31%-40.52%139.05%
Other Current Assets
0.940.70.810.993.971.35
Total Current Assets
79.1183.122.274240.1662.2
Net Property, Plant & Equipment
--0.010.010.02-
Other Intangible Assets
---0.020.040.05
Goodwill
14.8714.8714.8714.8714.8714.87
Other Long-Term Assets
0.05-----
Total Assets
94.0397.9737.1456.955.0977.12
Accounts Payable
2.120.641.611.810.971.85
Accrued Expenses
2.361.651.231.540.410.97
Total Current Liabilities
4.482.292.843.341.382.82
Long-Term Debt
60606082.0273.7366.33
Other Long-Term Liabilities
278.6171.47----
Total Long-Term Liabilities
338.6231.476082.0273.7366.33
Total Liabilities
343.08233.7662.8485.3675.1169.15
Common Stock
000000
Additional Paid-in Capital
560.19548.05369.68368.36346.79342.68
Retained Earnings
-814.2-688.8-395.38-396.82-366.81-334.7
Total Common Shareholders' Equity
-254.01-140.75-25.69-28.46-20.027.98
Minority Interest
4.964.96----
Shareholders' Equity
-249.05-135.79-25.69-28.46-20.027.98
Total Liabilities & Equity
94.0397.9737.1456.955.0977.12
Total Debt
60606082.0273.7366.33
Net Cash (Debt)
18.1622.4-38.54-41-37.54-5.47
Net Cash Growth
-18.91%-----
Net Cash Per Share
1.042.65-5.09-6.30-6.99-1.02
Book Value
-254.01-140.75-25.69-28.46-20.027.98
Book Value Per Share
-14.48-16.63-3.39-4.37-3.731.49
Tangible Book Value
-268.88-155.62-40.56-43.34-34.94-6.94
Tangible Book Value Per Share
-15.33-18.39-5.36-6.66-6.51-1.30
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q